David M. Loeb

https://assets.montefioreeinstein.org/profiles/images/Loeb_David_MD_2x.jpg

First Name

David

Last Name

Loeb

NPI

1841236676

Faculty ID

15556

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Loeb has an active translational research laboratory focused on understanding bone tumor metastasis.&nbsp; His laboratory developed a clinically relevant mouse model of sarcoma metastasis, and has used this model to perform preclinical testing of novel agents that can interfere with this process.&nbsp; More basic scientific studies in the lab involve exploring the role of the Wnt signaling pathway in Ewing sarcoma migration, invasion, and metastasis.&nbsp; Dr. Loeb is also studying the role of an enzyme called RNA helicase DDX3 in Ewing sarcoma biology, especially how this enzyme affects the repair of damaged DNA. More recently, the laboratory has developed an interest in targeting the metabolic reprogramming associated with metastasis as a way to prevent the outgrowth of distant metastases from disseminated tumor cells.</p>
<p>&nbsp;</p>
<p>Dr. Loeb is also actively involved in clinical research, including the development of radiopharmaceutical agents for the treatment of bone metastases and the development of a small molecule inhibitor of DDX3.&nbsp; He serves as the local PI for a clinical trial of reduced intensity haploidentical bone marrow transplantation for children with high risk solid tumors.&nbsp; Finally, as an offshoot of his laboratory work, Dr. Loeb is involved in the development of biomarkers of metastatic risk and of minimal residual disease in children, adolescents, and young adults with sarcomas.</p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Loeb is a leading pediatric oncologist and NIH-funded researcher. He has extensive expertise in sarcoma research and clinical care and is a bone marrow transplantation specialist. Dr. Loeb’s research spans the spectrum from basic and translational studies to clinical trials using novel therapies.</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

Selected Publications

<p>Dr. Loeb's PubMed bibliography can be found here: &nbsp;</p>
<p><a href="https://www.ncbi.nlm.nih.gov/sites/myncbi/1fiIspwqfwUE46/bibliography/5…;

EMR ID

6405

Biography

<p>David Loeb, MD, PhD, is Chief, Pediatric Hematology, Oncology and Cellular Therapy at Children&rsquo;s Hospital at Montefiore and Professor, Pediatrics and Professor, Developmental and Molecular Biology at Montefiore Einstein. His clinical work focuses on tumors of connective tissue, such as bone and muscle. He also has expertise in the care of children with other solid tumors. As a member of the bone marrow transplantation team, Dr. Loeb also cares for patients with acute leukemias and has expertise in the application of immunotherapy to childhood cancer.</p><p>Dr. Loeb earned his Bachelor of Arts in biology in 1987 at Johns Hopkins University. In 1993, he received his Doctor of Philosophy in Pathology and, in 1994, his Doctor of Medicine at Columbia University. In 1994, he also began an internship in Pediatrics at the Johns Hopkins University School of Medicine, followed by a residency in 1995 and a fellowship in Pediatric Hematology Oncology at the same institution.</p><p>Dr. Loeb has an active translational research laboratory focused on understanding bone tumor metastasis. His laboratory developed a clinically relevant mouse model of sarcoma metastasis and has used this model to perform preclinical testing of novel agents that can interfere with this process. One area of focus is the metabolic differences between cancer cells and normal cells, and between metastases and the primary tumor, with the intention of targeting these differences therapeutically. More basic scientific studies in the lab involve exploring the role of the Wnt signaling pathway in Ewing sarcoma and osteosarcoma migration, invasion and metastasis. Dr. Loeb also studies the role of an enzyme called RNA helicase DDX3 in Ewing sarcoma biology, especially how this enzyme affects the repair of damaged DNA.</p><p>Dr. Loeb is also actively involved in clinical research, including the development of radiopharmaceutical agents for the treatment of bone metastases and the development of a small molecule inhibitor of DDX3. He has also directed a clinical trial of reduced intensity haploidentical bone marrow transplantation for children with high risk solid tumors. Stemming from his laboratory work, Dr. Loeb is involved in the development of biomarkers of metastatic risk and of minimal residual disease in children, adolescents and young adults with sarcomas. Dr. Loeb&rsquo;s original research, based on his clinical and laboratory studies, has been published in multiple journals and books.</p><p>Dr. Loeb has been a recipient of many awards, including the Director&rsquo;s Teaching Award in Clinical Science from Sidney Kimmel Comprehensive Cancer Center in 2006, 2010 and 2015, and The Justin Straus Chordoma Research Award in 2009.</p>

Is Open Scheduling

Off

Anna Y. Zolotnitskaya

https://assets.montefioreeinstein.org/profiles/images/Zolotnitskaya_Anna_MD_2x_0.jpg

First Name

Anna

Last Name

Zolotnitskaya

NPI

1316949100

Faculty ID

1899

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

31006

Biography

<p>Anna Zolotnitskaya, MD, is Medical Director, Pediatric Dialysis at the Children&rsquo;s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Zolotnitskaya&rsquo;s clinical focus is on pediatric dialysis and pediatric renal transplantation. She leads a multidisciplinary dialysis team that provides patient-centered, evidence-based care for children and young adults with end-stage kidney disease. </p><p>After obtaining her Doctor of Medicine at St. Petersburg Pediatric Academy in St. Petersburg, Russia, in 1983, Dr. Zolotnitskaya completed her pediatrics internship at the same institution in 1984. She remained there to complete her pediatrics residency in 1989, before completing an additional pediatrics residency at Soroka Medical Center in Beer-Sheva, Israel, in 1994. Following this, Dr. Zolotnitskaya completed a pediatric nephrology fellowship at Montefiore Einstein in 1998, followed by an additional pediatrics residency at Columbia University College of Physicians and Surgeons, St. Luke&rsquo;s-Roosevelt Hospital in 2001. </p><p>Dr. Zolotnitskaya has been principal investigator and co-investigator in clinical trials that investigate medications employed for the care of children with advanced chronic kidney disease. Her work has been published in numerous peer-reviewed journals and abstracts, and she has given several invited presentations. She is also a reviewer for the <em>Journal of Pediatrics: Clinical Practice</em>. </p><p>Dr. Zolotnitskaya is board certified by the American Board of Pediatric Nephrology, the American Board of Pediatrics and the Israeli Board of Pediatrics. She is a member of the American Academy of Pediatrics, the American Society of Nephrology and the American Society of Pediatric Nephrology.

</p>

Is Open Scheduling

Off

Shiu M. Young

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Shiu

Last Name

Young

NPI

1467742726

Faculty ID

14110

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5826

Is Open Scheduling

Off

Daniel A. Weiser

https://assets.montefioreeinstein.org/profiles/images/Weiser_Daniel_MD_2x.jpg

First Name

Daniel

Last Name

Weiser

NPI

1225239700

Faculty ID

13846

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="text-decoration: underline;"><strong>Childhood cancer research laboratory</strong></span></p>
<p>Our laboratory is focused on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. In such patients with typically incurable cancer, we are striving to identify new approaches to and types of treatment. We have multiple ongoing projects:</p>
<p><strong>+ Identification of biologic drivers of ultra-high-risk neuroblastoma</strong>. Neuroblastoma is one of the most common and deadly childhood cancers. Despite intensive research, there are limited therapeutic strategies for patients with <em>de novo </em>chemotherapy resistance that leads to particularly poor outcomes. We have been studying neuroblastoma since 2009 and are identifying additional biologic drivers of highly lethal tumors.</p>
<p>We compare tumor features from patients with early death from tumor progression compared to those with a maintained complete response. We assess unique histo-morphologic and proteomic features and computationally integrate these data with genomic and transcriptomic datasets to develop a combined predictor of primary refractory disease. Patients with this entity require non-standard and/or intensified treatment. Oncogenic drivers are being characterized in the lab which will facilitate strategies for novel pharmacologic intervention.</p>
<p><strong>+ Characterization of neuroblastoma development from neural crest cells</strong>.&nbsp; We are studying pathways and interactions that results in uncontrolled cell proliferation early in neuroblastoma development with an ultimate goal of identifying new targets and approaches for pharmacologic intervention.</p>
<p><strong>+ Evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma</strong>.&nbsp; With expected outcomes lagging behind those of more common childhood cancers, children with neuroblastoma require new approaches to treatment. Our lab works with multiple international clinical and research consortium groups to perform preclinical studies that substantiate human clinical trials.&nbsp;</p>
<p><strong>+ Detection of circulating tumor DNA in osteosarcoma</strong>. With no reliable non-invasive approach for disease monitoring during and after treatment, we are applying cutting edge next-generation sequencing approaches to identify solid tumors with a blood-based &ldquo;liquid&rdquo; biopsies. This will allow clinicians to assess tumor responsiveness to chemotherapy and predict likelihood of recurrence.</p>
<p><strong>+ Assessment of accelerated aging using miRNA-seq in survivors of childhood cancer</strong>. Chemotherapy has many untoward effects on healthy cells and leads to many signs of accelerated aging in children treated for cancer. Using a known microRNA &ldquo;aging&rdquo; signature discovered at Albert Einstein College of Medicine, we are studying what causes this phenotype in childhood cancer, with a goal of offering improved intervention to minimize long-term toxicity of treatment.</p>
<p><strong><span style="text-decoration: underline;">Physician Summary</span></strong></p>
<p>Daniel A. Weiser, MD, is board-certified in pediatric hematology/oncology with clinical expertise in neuroblastoma and other tumors of the adrenal glands, kidneys, liver, and gonads. He is the medical director of the intra-abdominal solid tumor program at the Children&rsquo;s Hospital at Montefiore and brings together a highly specialized multi-disciplinary care team to provide comprehensive treatment for diverse pediatric malignancies. In addition, Dr. Weiser directs a childhood cancer research laboratory that focuses on the identification of new targeted agents for cancer therapy, especially in the treatment of rare and aggressive malignancies such as neuroblastoma. His research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise for improving management of all patients with solid tumors.</p>
<p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Advances in Neuroblastoma Research Association (ANRA), National Pediatric Cancer Foundation (NPCF), and the American Academy of Pediatrics (AAP). He has received numerous awards including the Brigid Leventhal Special Merit Award from ASCO and the Conquer Cancer Foundation, and a prestigious K12 from the National Cancer Institute for the training of the next generation of physician-scientists in pediatric cancer. Dr. Weiser is actively involved in teaching and mentorship of trainees, and takes great pride in providing advanced and compassionate care to his patients and their families.</p>
<p><strong>Clinical Expertise</strong></p>
<ul>
<li>Neuroblastoma (adrenal tumors)</li>
<li>Wilms tumor (renal tumors)</li>
<li>Hepatoblastoma (liver tumors)</li>
<li>Germ cell tumors (including testicular and ovarian tumors)</li>
<li>Thyroid and other rare tumors</li>
<li>Experimental therapeutics</li>
<li>Cancer genetics and biomarkers</li>
</ul>
<p><strong>Board Certifications</strong></p>
<ul>
<li>Pediatrics</li>
<li>Pediatric Hematology/Oncology</li>
</ul>
<p><strong>Professional Education</strong></p>
<ul>
<li>M.D. &ndash; Stony Brook University, NY</li>
<li>Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Chief Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Fellowship &ndash; The Children&rsquo;s Hospital of Philadelphia, PA</li>
</ul>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

DR. Weiser's clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma, and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers.&nbsp;

Research Focus

Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others.

Elsevier Profile

EMR ID

5755

Biography

<p>Daniel A. Weiser, MD, is a Medical Director of the Intra-abdominal Solid Tumor Program in the Pediatrics Hematology/Oncology department at Children&rsquo;s Hospital at Montefiore. He is also Associate Professor in the Pediatrics and Genetics departments at the Albert Einstein College of Medicine. His clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers. Dr. Weiser is actively involved in teaching and mentorship of trainees and takes great pride in his active participation in patient care.</p><p>Dr. Weiser received his Bachelor of Science in Neurobiology in 1995 at Haverford College, PA. In 2004, he received his Doctor of Medicine at Stony Brook University School of Medicine, NY. He is currently earning his Master of Science in Translational Research at the University of Pennsylvania. He began a residency in Pediatrics at the New York-Presbyterian, Columbia University in 2007. Dr. Weiser then completed a three-year fellowship in Pediatric Hematology/Oncology at The Children&rsquo;s Hospital of Philadelphia. </p><p>Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others. His research has been published in many reviewed journals. </p><p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and the American Academy of Pediatrics (AAP). He has received many awards including the Brigid Leventhal Special Merit Award through ASCO, and he has been awarded a prestigious K12 from the NCI for the training of the next generation of physician-scientists in pediatric cancer.</p><p>He is board certified in Pediatric Hematology/Oncology and General Pediatrics.</p>

Is Open Scheduling

Off

Jacqueline Weingarten-Arams

https://assets.montefioreeinstein.org/profiles/images/physphoto/Weingarten_Jacqueline_MD_420x504.jpg

First Name

Jacqueline

Last Name

Weingarten-Arams

NPI

1558447409

Faculty ID

4831

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

Lab Website Link

EMR ID

3961

Biography

<p>Jacqueline Weingarten-Arams, MD, is an attending physician and Professor, Pediatrics at Montefiore Einstein. Dr. Weingarten-Arams&rsquo; pediatric critical care expertise focuses on cardiac critical care, acute hypoxemic respiratory failure, nutrition in critical illness and energy expenditure, cardiopulmonary resuscitation (quality CPR) and extracorporeal life support (ECMO).</p><p>After obtaining her Bachelor of Science in nutritional biochemistry at Cornell University in 1982, Dr. Weingarten-Arams earned her Doctor of Medicine at the same institution in 1986. She then completed her pediatric residency at Columbia University in 1990, where she was Chief Resident in her final year. Following this, Dr. Weingarten-Arams completed a fellowship in pediatric critical care medicine at New York Hospital Cornell University Medical College in 1996.</p><p>Dr. Weingarten-Arams research focus includes the use of deliberate simulated practice in improving outcomes in pediatric critical illness, pediatric resuscitation and pediatric airway management. Her other projects involve chronic critical illness, bioethics in pediatric critical care and oxidative injury in respiratory failure. She has been principal investigator and co-investigator on several research projects, and her work has been shared through numerous peer-reviewed publications and invited presentations.</p><p>Dr. Weingarten-Arams is a Diplomate of the National Board of Medical Examiners and the American Board of Pediatrics. She is a Fellow of the American Academy of Pediatrics and the American College of Chest Physicians. She is also a member of several professional organizations, including the American Medical Association, the Pediatric Cardiac Intensive Care Society and the Society of Critical Care Medicine. Dr. Weingarten-Arams has been named in Castle Connolly&rsquo;s &ldquo;Top Doctors: New York Metro Area&rdquo; for multiple years. In 2006, she was inducted into the Leo M. Davidoff Society and in 2019, Dr. Weingarten-Arams won the William Obrinsky Award for Excellence in Medical Student Education.</p>

Is Open Scheduling

Off

Henry Michael Ushay

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ushay_Michael_MD_420x504.jpg

First Name

Henry

Last Name

Ushay

NPI

1558332007

Faculty ID

10275

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric critical care medicine with a special emphasis on respiratory failure; shock resuscitation; cardiac intensive care; intensive care of pediatric oncology patients; extracorporeal support for children with respiratory and cardiovascular failure

Research Focus

Leadership and direction of the 16-bed Pediatric Critical Care Unit of The Children&rsquo;s Hospital at Montefiore; improving medication safety; respiratory physiology; advances in the management of respiratory failure in children; shock; medical ethics

Elsevier Profile

EMR ID

4763

Biography

<p>Dr. Ushay is Professor of Clinical Pediatrics in the Albert Einstein College of Medicine. He is a Fellow of the American Academy of Pediatrics as well as a Fellow of the American College of Critical Care Medicine. </p><p>After obtaining a PhD in Chemistry from Columbia University, Dr. Ushay received his MD from UMDNJ-New Jersey Medical School and completed a Pediatrics residency in the Montefiore-Jacobi-Einstein program. After serving as Chief Resident and a Fellow in Pediatric Pulmonology at Montefiore, he completed a Pediatric Critical Care Fellowship at New York Hospital/Cornell Medical Center in 1993. He was a faculty member at NewYork-Presbyterian and Memorial Sloan-Kettering Hospitals from 1993 to 2005, and he served as Pediatric Critical Care Medicine Fellowship Program Director and Medical Director of the Pediatric Observation Unit at Memorial Sloan-Kettering Cancer Center. </p><p>In 2005 Dr. Ushay became Director of the Pediatric Critical Care Unit in The Children&rsquo;s Hospital at Montefiore. Dr. Ushay is involved in increasing pediatric ICU surge capacity through the New York City Pediatric Disaster Coalition, serving on its Central Leadership Council and teaching the Pediatric Fundamental Critical Care Support Course. Through the National Institute of Child Health and Human Development, Dr. Ushay works on employing medical countermeasures safely for children in the event of chemical, biological or radiological disaster. Sponsored by Surgeons of Hope and Children&rsquo;s HeartLink, Dr. Ushay has worked as a cardiac intensivist in Cambodia, Africa, China and Nicaragua. </p>

Is Open Scheduling

Off

Alecia M. Thompson

https://assets.montefioreeinstein.org/profiles/images/Thompson_Alecia_MD_420x540.jpg

First Name

Alecia

Last Name

Thompson

NPI

1992930796

Faculty ID

12295

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

On

Professional Title

Research Focus

Dr. Thompson-Branch's research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis.

Elsevier Profile

EMR ID

5397

Biography

<p>With an emphasis on general pediatrics and neonatology, Dr. Thompson completed her residency at NYU Medical Center in 2007 and fellowship at Yale-New Haven Hospital in 2010. During her fellowship, Dr. Thompson also audited the Robert Wood Johnson Clinical Scholars Program, with an interest in performing clinical research. Her research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis. She plans to conduct research on the use of near-infrared spectroscopy to delineate central nervous system pathology in preterm infants and predict short-term neurologic outcomes.</p>

Is Open Scheduling

Off

Mark Shlomovich

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f00957b0-d372-11ed-b9ca-f36b2b5dc5fe.jpg

First Name

Mark

Last Name

Shlomovich

NPI

1790065910

Faculty ID

15549

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

29419

Biography

<p>Mark Shlomovich, MD, is Director, Extracorporeal Liver Support and Director, Pediatric Critical Care Transport at Children&rsquo;s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Shlomovich&rsquo;s clinical focus is on the care of critically ill children with abdominal organ failure, transplantation and post-surgical care. He also focuses on the safe transportation of critically ill children.</p><p>In 2006, Dr. Shlomovich earned his Bachelor of Science in biology from Towson University. He then attended University of Connecticut School of Medicine earning his Doctor of Medicine in 2010. His postgraduate training began at SUNY Downstate Medical Center with a four-year pediatric residency, where he was Chief Pediatric Resident in his final year. He then came to Children's Hospital at Montefiore for a pediatric critical care fellowship, which he completed in 2017.</p><p>Dr. Shlomovich&rsquo;s research interests are in the use of artificial liver support technology, as well as the care of children in liver failure before and after transplantation. In addition, he investigates the safety and efficiency of the transportation of critically ill children. He has shared his research through peer-reviewed journals and abstracts, and is an ad hoc reviewer for BMC Nephrology.</p><p>Dr. Shlomovich is board certified in general pediatrics and pediatric critical care medicine. He is a member of the Society of Critical Care Medicine and the American Academy of Pediatrics.</p>

Is Open Scheduling

Off

Ariel L. Shiloh

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4f28f3b0-3caf-11ec-80f7-67047826a941.jpg

First Name

Ariel

Last Name

Shiloh

NPI

1346561891

Faculty ID

12325

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="background: white;">Dr. Shiloh is the Director of the Critical Care Medicine Consult Service and Professor of Medicine at Montefiore Medical Center/Albert Einstein College of Medicine. As a clinician-educator he serves as the director of critical care ultrasonography.&nbsp;&nbsp;</p>
<p class="MsoNormal" style="background: white;">After receiving his medical degree from the Medical School for International Health at Ben Gurion University of the Negev in 2005, he completed both his Internal Medicine residency and Critical Care Medicine fellowship at Montefiore Medical Center/Albert Einstein College of Medicine. Dr. Shiloh joined the Montefiore/Einstein Critical Care faculty in 2010.&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;Dr. Shiloh is board-certified in:&nbsp;</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Internal Medicine</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Critical Care Medicine</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Neurocritical Care</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Hospice and Palliative Medicine</p>
<p class="MsoNormal" style="background: white;">As an active member of CHEST, Dr. Shiloh serves as faculty leader and co-chair for the Critical Care Ultrasound: Integration Into Clinical Practice course.&nbsp; He is an active contributor to CHEST&rsquo;s &ldquo;Better with Ultrasound&rdquo; and &ldquo;Ultrasound Corner&rdquo; series and a recipient of the &ldquo;Distinguished Chest Educator&rdquo; award.&nbsp;<span style="color: #262626; font-family: Verdana;">Award recipients represent the top 4% of CHEST&rsquo;s international faculty and are recognized for their achievements and long-term contributions to the design and delivery of CHEST education.</span></p>
<p class="MsoNormal" style="background: white;">Dr. Shiloh has authored over 50 original articles, co-edited the &ldquo;The 5-Minute ICU Consult&rdquo; published by Lippincott Williams &amp; Wilkins, and has authored over 15 book chapters. His areas of interest and research include use of point of care ultrasonography, early identification of critical illness, and critical care education and simulation training.&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Early Detection and Treatment of Critical Illness, Point Of Care Ultrasonography For The Evaluation Of Critical Illness, Advanced Airway Management

Research Focus

Dr. Shiloh's research includes the clinical use of point-of-care ultrasonography in critical illness, improvement of airway management, and cardiopulmonary resuscitation.

Elsevier Profile

Selected Publications

<p>1: Shah TE, Vij R, Kim YH, Shiloh AL. Sudden Unilateral Vision Loss in a Patient</p>
<p>Who Received Intravenous Thrombolytic Therapy. Chest. 2021 Dec;160(6):e669-e672.</p>
<p>doi: 10.1016/j.chest.2021.03.074. PMID: 34872684.</p>
<p>&nbsp;</p>
<p>2: Nauka PC, Chen JT, Shiloh AL, Eisen LA, Fein DG. Practice, Outcomes, and</p>
<p>Complications of Emergent Endotracheal Intubation by Critical Care Practitioners</p>
<p>During the COVID-19 Pandemic. Chest. 2021 Dec;160(6):2112-2122. doi:</p>
<p>10.1016/j.chest.2021.06.008. Epub 2021 Jun 15. PMID: 34139207; PMCID:</p>
<p>PMC8204844.</p>
<p>&nbsp;</p>
<p>3: Savel RH, Shiloh AL, Kupfer Y, Hope AA. The Complex Issue of Race and</p>
<p>Coronavirus Disease 2019 in the ICU. Crit Care Med. 2021 Mar 1;49(3):532-535.</p>
<p>doi: 10.1097/CCM.0000000000004766. PMID: 33616353.</p>
<p>&nbsp;</p>
<p>4: Jabbour E, Malik D, Shiloh AL. Sudden Cardiopulmonary Collapse in a Patient</p>
<p>With Coronavirus Disease 2019. Chest. 2021 Feb;159(2):e127-e129. doi:</p>
<p>10.1016/j.chest.2020.05.618. PMID: 33563455; PMCID: PMC7859694.</p>
<p>&nbsp;</p>
<p>5: Savel RH, Kupfer Y, Shiloh AL. Steady As She Goes: Practicing Evidence-Based</p>
<p>Critical Care When the Evidence Is Limited. Chest. 2021 Jan;159(1):7-8. doi:</p>
<p>10.1016/j.chest.2020.09.245. PMID: 33422231; PMCID: PMC7787062.</p>
<p>&nbsp;</p>
<p>6: Tirumandas M, Gendlina I, Figueredo J, Shiloh A, Trachuk P, Jain R, Corpuz M,</p>
<p>Spund B, Maity A, Shmunko D, Garcia M, Barthelemy D, Weston G, Madaline T.</p>
<p>Analysis of catheter utilization, central line associated bloodstream</p>
<p>infections, and costs associated with an inpatient critical care-driven vascular</p>
<p>access model. Am J Infect Control. 2021 May;49(5):582-585. doi:</p>
<p>10.1016/j.ajic.2020.10.006. Epub 2020 Oct 17. PMID: 33080360.</p>
<p>&nbsp;</p>
<p>7: Fein DG, Zhao D, Swartz K, Nauka P, Andrea L, Aboodi M, Shiloh AL, Eisen LA.</p>
<p>The Impact of Nighttime on First Pass Success During the Emergent Endotracheal</p>
<p>Intubation of Critically Ill Patients. J Intensive Care Med. 2021</p>
<p>Dec;36(12):1498-1506. doi: 10.1177/0885066620965166. Epub 2020 Oct 15. PMID:</p>
<p>33054483.</p>
<p>&nbsp;</p>
<p>8: Kapoor S, Chand S, Dieiev V, Fazzari M, Tanner T, Lewandowski DC, Nalla A,</p>
<p>Abdulfattah O, Aboodi MS, Shiloh AL, Gong MN. Thromboembolic Events and Role of</p>
<p>Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive</p>
<p>Care Unit Admission. J Intensive Care Med. 2021 Dec;36(12):1483-1490. doi:</p>
<p>10.1177/0885066620964392. Epub 2020 Oct 6. PMID: 33021131; PMCID: PMC7539230.</p>
<p>&nbsp;</p>
<p>9: Emami N, Tanner T, Ogundipe F, Hawn VS, Rubin R, Skae CC, Shiloh AL, Keene</p>
<p>AB. Drape to prevent disease transmission during endotracheal intubation. Am J</p>
<p>Infect Control. 2021 Mar;49(3):387-388. doi: 10.1016/j.ajic.2020.06.212. Epub</p>
<p>2020 Jul 3. PMID: 32628982; PMCID: PMC7333628.</p>
<p>&nbsp;</p>
<p>10: Millington SJ, Colvin MO, Shiloh AL, Koenig S. How I Do It: Ultrasound-</p>
<p>Guided Internal Jugular and Femoral Central Venous Catheter Insertion. Chest.</p>
<p>2020 Dec;158(6):2425-2430. doi: 10.1016/j.chest.2020.06.026. Epub 2020 Jun 26.</p>
<p>PMID: 32599065.</p>
<p>&nbsp;</p>
<p>11: Savel RH, Shiloh AL, Saunders PC, Kupfer Y. Mechanical Ventilation During</p>
<p>the Coronavirus Disease 2019 Pandemic: Combating the Tsunami of Misinformation</p>
<p>From Mainstream and Social Media. Crit Care Med. 2020 Sep;48(9):1398-1400. doi:</p>
<p>10.1097/CCM.0000000000004462. PMID: 32496274; PMCID: PMC7302097.</p>
<p>&nbsp;</p>
<p>12: Shiloh AL, McPhee C, Eisen L, Koenig S, Millington SJ. Better With</p>
<p>Ultrasound: Detection of DVT. Chest. 2020 Sep;158(3):1122-1127. doi:</p>
<p>10.1016/j.chest.2020.01.038. Epub 2020 Feb 20. PMID: 32087215.</p>
<p>&nbsp;</p>
<p>13: Islam M, Levitus M, Eisen L, Shiloh AL, Fein D. Lung Ultrasound for the</p>
<p>Diagnosis and Management of Acute Respiratory Failure. Lung. 2020</p>
<p>Feb;198(1):1-11. doi: 10.1007/s00408-019-00309-1. Epub 2020 Jan 1. PMID:</p>
<p>31894411.</p>
<p>&nbsp;</p>
<p>14: Fein DG, Mastroianni F, Murphy CG, Aboodi M, Malik R, Emami N, Abramowitz M,</p>
<p>Shiloh AL, Eisen L. Impact of a Critical Care Specialist Intervention on First</p>
<p>Pass Success for Emergency Airway Management Outside the ICU. J Intensive Care</p>
<p>Med. 2021 Jan;36(1):80-88. doi: 10.1177/0885066619886816. Epub 2019 Nov 10.</p>
<p>PMID: 31707906.</p>
<p>&nbsp;</p>
<p>15: Millington SJ, Hendin A, Shiloh AL, Koenig S. Better With Ultrasound:</p>
<p>Peripheral Intravenous Catheter Insertion. Chest. 2020 Feb;157(2):369-375. doi:</p>
<p>10.1016/j.chest.2019.04.139. Epub 2019 Oct 22. PMID: 31654617.</p>
<p>&nbsp;</p>
<p>16: Wang A, Hendin A, Millington SJ, Koenig S, Eisen LA, Shiloh AL. Better With</p>
<p>Ultrasound: Arterial Line Placement. Chest. 2020 Mar;157(3):574-579. doi:</p>
<p>10.1016/j.chest.2019.08.2209. Epub 2019 Oct 18. PMID: 31634448.</p>
<p>&nbsp;</p>
<p>17: Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Getting It Right for Our Patients:</p>
<p>The Importance of Collaborative Leadership in the ICU. Crit Care Med. 2019</p>
<p>Sep;47(9):1279-1281. doi: 10.1097/CCM.0000000000003880. PMID: 31415316.</p>
<p>&nbsp;</p>
<p>18: Islam M, Bangar M, Shiloh AL. A Woman in Her 70s on Anticoagulation With</p>
<p>Sudden Shock. Chest. 2019 May;155(5):e123-e126. doi:</p>
<p>10.1016/j.chest.2018.10.052. PMID: 31060707.</p>
<p>&nbsp;</p>
<p>19: Patrawalla P, Narasimhan M, Eisen L, Shiloh AL, Koenig S, Mayo P. A</p>
<p>Regional, Cost-Effective, Collaborative Model for Critical Care Fellows'</p>
<p>Ultrasonography Education. J Intensive Care Med. 2020 Dec;35(12):1447-1452. doi:</p>
<p>10.1177/0885066619828951. Epub 2019 Feb 12. PMID: 30755062.</p>
<p>&nbsp;</p>
<p>20: Shiloh AL. Smooth Transitions in Critical Care. J Emerg Trauma Shock. 2018</p>
<p>Jul-Sep;11(3):154-155. doi: 10.4103/JETS.JETS_44_17. PMID: 30429619; PMCID:</p>
<p>PMC6182967.</p>
<p>&nbsp;</p>
<p>21: Savel RH, Shiloh AL. Are We Really Doing More With Less: The Value of Half-</p>
<p>Dose Alteplase in Pulmonary Embolism Therapy. Crit Care Med. 2018</p>
<p>Oct;46(10):1696-1697. doi: 10.1097/CCM.0000000000003303. PMID: 30216306.</p>
<p>&nbsp;</p>
<p>22: Savel RH, Borgia D, Shiloh AL. A Path to High-Quality Care: Implementing</p>
<p>Flexible Visitation While Avoiding Staff Burnout. Crit Care Med. 2018</p>
<p>Jul;46(7):1203-1204. doi: 10.1097/CCM.0000000000003167. PMID: 29912108.</p>
<p>&nbsp;</p>
<p>23: Ferenchick HR, Chua AT, Carlese AJ, Shiloh AL. A Woman With Recent Stroke</p>
<p>Presenting With Respiratory Failure and Shock. Chest. 2018 May;153(5):e101-e103.</p>
<p>doi: 10.1016/j.chest.2017.11.048. PMID: 29731049.</p>
<p>&nbsp;</p>
<p>24: Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Using Big Data to See the Big</p>
<p>Picture in Sepsis. Crit Care Med. 2018 Apr;46(4):640-641. doi:</p>
<p>10.1097/CCM.0000000000002976. PMID: 29538113.</p>
<p>&nbsp;</p>
<p>25: Kumarasamy N, Tishbi N, Mukundan S, Shiloh A, Levsky JM, Haramati LB.</p>
<p>Cardiothoracic MRI in the ICU: A 10-Year Experience. Acad Radiol. 2018</p>
<p>Mar;25(3):359-364. doi: 10.1016/j.acra.2017.09.017. Epub 2018 Feb 6. PMID:</p>
<p>29426683.</p>
<p>&nbsp;</p>
<p>26: Lishmanov A, Bellamkonda TT, Shiloh AL. A Woman in Her 20s With</p>
<p>Cardiopulmonary Failure. Chest. 2017 Jun;151(6):e123-e125. doi:</p>
<p>10.1016/j.chest.2017.01.040. PMID: 28599944.</p>
<p>&nbsp;</p>
<p>27: Shiloh AL, Sobolev M, Di Biase L, Slovut DP. A call for safety during</p>
<p>electrophysiological procedures: US in, why not US out? Authors' reply.</p>
<p>Europace. 2017 Dec 1;19(12):2048-2049. doi: 10.1093/europace/eux007. PMID:</p>
<p>28340047.</p>
<p>&nbsp;</p>
<p>28: Sobolev M, Shiloh AL, Di Biase L, Slovut DP. Ultrasound-guided cannulation</p>
<p>of the femoral vein in electrophysiological procedures: a systematic review and</p>
<p>meta-analysis. Europace. 2017 May 1;19(5):850-855. doi: 10.1093/europace/euw113.</p>
<p>PMID: 27207813.</p>
<p>&nbsp;</p>
<p>29: Shiloh AL, Lominadze G, Gong MN, Savel RH. Early Warning/Track-and-Trigger</p>
<p>Systems to Detect Deterioration and Improve Outcomes in Hospitalized Patients.</p>
<p>Semin Respir Crit Care Med. 2016 Feb;37(1):88-95. doi: 10.1055/s-0035-1570352.</p>
<p>Epub 2016 Jan 28. PMID: 26820276.</p>
<p>&nbsp;</p>
<p>30: Patrawalla P, Eisen LA, Shiloh A, Shah BJ, Savenkov O, Wise W, Evans L, Mayo</p>
<p>P, Szyld D. Development and Validation of an Assessment Tool for Competency in</p>
<p>Critical Care Ultrasound. J Grad Med Educ. 2015 Dec;7(4):567-73. doi:</p>
<p>10.4300/JGME-D-14-00613.1. PMID: 26692968; PMCID: PMC4675413.</p>
<p>&nbsp;</p>
<p>31: Hena KM, Eisen LA, Shiloh AL. A Man in His 60s With Renal Failure and Shock</p>
<p>Refractory to Vasopressors. Chest. 2015 Dec;148(6):e171-e174. doi:</p>
<p>10.1378/chest.15-0160. PMID: 26621295.</p>
<p>&nbsp;</p>
<p>32: Bernier-Jean A, Albert M, Shiloh AL, Eisen LA, Williamson D, Beaulieu Y. The</p>
<p>Diagnostic and Therapeutic Impact of Point-of-Care Ultrasonography in the</p>
<p>Intensive Care Unit. J Intensive Care Med. 2017 Mar;32(3):197-203. doi:</p>
<p>10.1177/0885066615606682. Epub 2016 Jul 9. PMID: 26423745.</p>
<p>&nbsp;</p>
<p>33: Shiloh AL, Adrish M. A Man in His 60s With Cirrhosis, Encephalopathy, and</p>
<p>Shock. Chest. 2015 Jul;148(1):e5-e7. doi: 10.1378/chest.14-2201. PMID: 26149567.</p>
<p>&nbsp;</p>
<p>34: Sobolev M, Slovut DP, Lee Chang A, Shiloh AL, Eisen LA. Ultrasound-Guided</p>
<p>Catheterization of the Femoral Artery: A Systematic Review and Meta-Analysis of</p>
<p>Randomized Controlled Trials. J Invasive Cardiol. 2015 Jul;27(7):318-23. PMID:</p>
<p>26136279.</p>
<p>&nbsp;</p>
<p>35: Adrish M, Shiloh AL. A woman in her 50s with recent coronary artery bypass</p>
<p>grafting presenting with right-sided chest pain. Chest. 2015</p>
<p>May;147(5):e171-e174. doi: 10.1378/chest.14-0457. PMID: 25940259.</p>
<p>&nbsp;</p>
<p>36: Shiloh AL, Ari Eisen L, Savel RH. The unplanned intensive care unit</p>
<p>admission. J Crit Care. 2015 Apr;30(2):419-20. doi: 10.1016/j.jcrc.2014.12.010.</p>
<p>Epub 2014 Dec 24. PMID: 25579373.</p>
<p>&nbsp;</p>
<p>37: Eisen LA, Savel RH, Shiloh AL. Video laryngoscopy in the intensive care</p>
<p>unit. A clearer view? Ann Am Thorac Soc. 2014 Oct;11(8):1254-5. doi:</p>
<p>10.1513/AnnalsATS.201408-386ED. PMID: 25343195.</p>
<p>&nbsp;</p>
<p>38: Chung M, Shiloh AL, Carlese A. Monitoring of the adult patient on</p>
<p>venoarterial extracorporeal membrane oxygenation. ScientificWorldJournal.</p>
<p>2014;2014:393258. doi: 10.1155/2014/393258. Epub 2014 Apr 3. PMID: 24977195;</p>
<p>PMCID: PMC3998007.</p>
<p>&nbsp;</p>
<p>39: Karakitsos D, El Barbary M, Gillman LM, Papalois A, Shiloh A. Critical care</p>
<p>and perioperative monitoring. ScientificWorldJournal. 2014;2014:737628. doi:</p>
<p>10.1155/2014/737628. Epub 2014 May 4. PMID: 24892082; PMCID: PMC4032705.</p>
<p>&nbsp;</p>
<p>40: Tischenkel BR, Gong MN, Shiloh AL, Pittignano VC, Keschner YG, Glueck JA,</p>
<p>Cohen HW, Eisen LA. Daytime Versus Nighttime Extubations: A Comparison of</p>
<p>Reintubation, Length of Stay, and Mortality. J Intensive Care Med. 2016</p>
<p>Feb;31(2):118-26. doi: 10.1177/0885066614531392. Epub 2014 Apr 24. PMID:</p>
<p>24763118.</p>
<p>&nbsp;</p>
<p>41: Shiloh AL, Kazzi MG, Mathew R, Eisen LA, Carlese AJ. A man in his 40s with a</p>
<p>history of hypertension and alcohol dependency presenting to the ED with</p>
<p>respiratory distress: septic shock in the setting of ARDS. Chest. 2014</p>
<p>Feb;145(2):e3-e6. doi: 10.1378/chest.13-2089. PMID: 24493554.</p>
<p>&nbsp;</p>
<p>42: Shiloh AL, Sobolev M, Eisen LA. A woman in her 30s in respiratory distress</p>
<p>with a history of gestational diabetes and hypertension. Chest. 2014</p>
<p>Jan;145(1):e1-e2. doi: 10.1378/chest.13-1850. PMID: 24394849.</p>
<p>&nbsp;</p>
<p>43: Lahiri S, Boro AD, Shiloh AL, Milstein MJ, Savel RH. Periodic Epileptiform</p>
<p>Discharges Clarified for the Nonneurologist Intensivist: Clinical Implications</p>
<p>and Current Management. J Intensive Care Med. 2015 Oct;30(7):385-91. doi:</p>
<p>10.1177/0885066613513411. Epub 2013 Dec 9. PMID: 24323590.</p>
<p>&nbsp;</p>
<p>44: Eisen LA, Janowski W, Shiloh AL. Ultrasound diagnosis of shock in a woman</p>
<p>with metastatic renal cell carcinoma. Chest. 2013 Sep;144(3):e1-e3. doi:</p>
<p>10.1378/chest.13-0964. PMID: 24008972.</p>
<p>&nbsp;</p>
<p>45: Savel RH, Shiloh AL, Eisen LA. Tackling the tough questions: what was this</p>
<p>patient like before they were critically ill? Crit Care Med. 2013</p>
<p>Jan;41(1):327-8. doi: 10.1097/CCM.0b013e318267a8ad. PMID: 23269133.</p>
<p>&nbsp;</p>
<p>46: Shiloh AL, Eisen LA, Yee M, Langner JB, LeDonne J, Karakitsos D. Ultrasound-</p>
<p>guided subclavian and axillary vein cannulation via an infraclavicular approach:</p>
<p>In the tradition of Robert Aubaniac. Crit Care Med. 2012 Oct;40(10):2922-3. doi:</p>
<p>10.1097/CCM.0b013e31825cea64. PMID: 22986669.</p>
<p>&nbsp;</p>
<p>47: Keene AB, Shiloh AL, Dudaie R, Eisen LA, Savel RH. Online testing from</p>
<p>Google Docs&trade; to enhance teaching of core topics in critical care: a pilot study.</p>
<p>Med Teach. 2012;34(12):1075-7. doi: 10.3109/0142159X.2012.716553. Epub 2012 Aug</p>
<p>30. PMID: 22931149.</p>
<p>&nbsp;</p>
<p>48: Stefanidis K, Pentilas N, Dimopoulos S, Nanas S, Savel RH, Shiloh AL,</p>
<p>Poularas J, Slama M, Karakitsos D. Echogenic Technology Improves Cannula</p>
<p>Visibility during Ultrasound-Guided Internal Jugular Vein Catheterization via a</p>
<p>Transverse Approach. Crit Care Res Pract. 2012;2012:306182. doi:</p>
<p>10.1155/2012/306182. Epub 2012 May 10. PMID: 22649715; PMCID: PMC3357505.</p>
<p>&nbsp;</p>
<p>49: Stefanidis K, Fragou M, Pentilas N, Kouraklis G, Nanas S, Savel RH, Shiloh</p>
<p>AL, Slama M, Karakitsos D. Optimization of Cannula Visibility during Ultrasound-</p>
<p>Guided Subclavian Vein Catheterization, via a Longitudinal Approach, by</p>
<p>Implementing Echogenic Technology. Crit Care Res Pract. 2012;2012:617149. doi:</p>
<p>10.1155/2012/617149. Epub 2012 Apr 23. PMID: 22593825; PMCID: PMC3347863.</p>
<p>&nbsp;</p>
<p>50: Savel RH, Shiloh AL, Eisen LA. Educational impact of continuous chest</p>
<p>compression cardiopulmonary resuscitation: the confidence to "pay it forward"*.</p>
<p>Crit Care Med. 2012 Mar;40(3):992-3. doi: 10.1097/CCM.0b013e31823878b1. PMID:</p>
<p>22343848.</p>
<p>&nbsp;</p>
<p>51: Shiloh AL, Eisen LA, Savel RH. Goal-directed ultrasonography in the</p>
<p>intensive care unit: no more excuses! Crit Care Med. 2011 Apr;39(4):879-80. doi:</p>
<p>10.1097/CCM.0b013e318208e393. PMID: 21613832.</p>
<p>&nbsp;</p>
<p>52: Rosenberg JB, Shiloh AL, Savel RH, Eisen LA. Non-invasive methods of</p>
<p>estimating intracranial pressure. Neurocrit Care. 2011 Dec;15(3):599-608. doi:</p>
<p>10.1007/s12028-011-9545-4. PMID: 21519957.</p>
<p>&nbsp;</p>
<p>53: Kory PD, Pellecchia CM, Shiloh AL, Mayo PH, DiBello C, Koenig S. Accuracy of</p>
<p>ultrasonography performed by critical care physicians for the diagnosis of DVT.</p>
<p>Chest. 2011 Mar;139(3):538-542. doi: 10.1378/chest.10-1479. Epub 2010 Oct 28.</p>
<p>PMID: 21030490.</p>
<p>&nbsp;</p>
<p>54: Shiloh AL, Savel RH, Paulin LM, Eisen LA. Ultrasound-guided catheterization</p>
<p>of the radial artery: a systematic review and meta-analysis of randomized</p>
<p>controlled trials. Chest. 2011 Mar;139(3):524-529. doi: 10.1378/chest.10-0919.</p>
<p>Epub 2010 Aug 19. PMID: 20724734.</p>
<p>&nbsp;</p>
<p>55: Shiloh AL, Eisen LA, Savel RH. Selective decontamination of the digestive</p>
<p>tract: what outcomes matter? Crit Care Med. 2010 May;38(5):1386-7. doi:</p>
<p>10.1097/CCM.0b013e3181da47d1. PMID: 20404637.</p>
<p>&nbsp;</p>
<p>56: Shiloh AL, Eisen LA. Ultrasound-guided arterial catheterization: a narrative</p>
<p>review. Intensive Care Med. 2010 Feb;36(2):214-21. doi:</p>
<p>10.1007/s00134-009-1699-6. Epub 2009 Oct 31. PMID: 19882140.</p>
<p>&nbsp;</p>
<p>57: Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W. Deubiquitination of</p>
<p>p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002 Apr</p>
<p>11;416(6881):648-53. doi: 10.1038/nature737. Epub 2002 Mar 31. PMID: 11923872.</p>

EMR ID

4723

Biography

<p>Ariel L Shiloh, MD, is Director, Critical Care Consult Services, Professor, Medicine and Associate Professor, Neurology at Montefiore Einstein. Dr. Shiloh&rsquo;s clinical interests include the early detection and treatment of critical illness, point-of-care ultrasonography for the evaluation of critical illness and advanced airway management.</p><p>After earning his Bachelor of Arts from Yeshiva University, Dr. Shiloh attended the Medical School for International Health at Ben Gurion University, Be&rsquo;er Sheva, Israel, earning his Doctor of Medicine in 2005. He came to Montefiore for his postdoctoral training, completing his internship and residency in internal medicine in 2008, followed by his fellowship in critical care medicine in 2010.</p><p>Dr. Shiloh's research includes the clinical use of point-of-care ultrasonography in critical illness, improvement of airway management, and cardiopulmonary resuscitation. He has shared his work through peer-reviewed journals, invited presentations, books, abstracts and poster presentations at national conferences. He has also been a reviewer for several journals including <em>Chest</em>, the <em>American Journal of Critical Care</em> and the <em>European Journal of Anesthesiology</em>.</p><p>Dr. Shiloh is board certified in Internal Medicine, Critical Care Medicine and Neurocritical Care and Hospice &amp; Palliative Medicine. He is a Fellow of the American College of Chest Physicians and a member of the Society of Critical Care Medicine. Dr. Shiloh has been recognized by the American College of Chest Physicians as a Distinguished CHEST Educator, among the top 5% of CHEST&rsquo;s international faculty recognized for long-term contributions to the design and delivery of CHEST education</p>

Is Open Scheduling

Off

Theresa M. Serra

https://assets.montefioreeinstein.org/profiles/images/Serra_Theresa_MD_2x.jpg

First Name

Theresa

Last Name

Serra

NPI

1609164078

Faculty ID

14280

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Medicine

Elsevier Profile

EMR ID

55674

Biography

<p class="MsoNormal">Theresa Serra, MD, joined the CHAM hospitalist division in 2014 after working as a pediatric hospitalist at New York Presbyterian/Lower Manhattan Hospital. Her interests include clinical research and medical education. She has conducted an IRB approved retrospective chart review examining readmission rates in pediatric patients diagnosed with osteomyelitis. Dr. Serra is currently developing a medical Spanish curriculum for faculty members in order to improve communication between patients, families and providers. Along with Courtney McNamara, MD, Dr. Serra is a co-leader of a multidisciplinary committee dedicated to standardizing and improving quality of care for patients hospitalized with the diagnosis of failure to thrive. Dr. Serra is also working on an initiative to identify vaccine delinquency in the inpatient setting through the use of SMART reports.</p> <p class="MsoNormal">Dr. Serra is also collaborating with Lindsey Douglas, MD, MSCR, in an IRB approved quality improvement (QI) project to improve transition-of-care communication between hospitalists and primary care providers and to facilitate the establishment of medical homes. Dr. Serra is also a member of a subcommittee that leads monthly journal clubs/case conferences for pediatric hospitalists.</p>

Is Open Scheduling

Off